Thyroid Gland Disorder Treatment Market Size, Analysis, Opportunities and Future Prospects 2025
A recent report by KD market insights titled as "Thyroid Gland Disorder Treatment Market Size, Trends &
Opportunity Outlook – Forecast to 2025" provides the key
trends, opportunities and challenges market will face in the forecasted period
of 6 years i.e. 2016-2025. The study also provides the Thyroid Gland Disorder Treatment Market. competitors share
and region wise analysis around the globe.
The global thyroid
gland disorder market was valued at $2,057 million in 2017, and is
estimated to reach $2,771 million at a CAGR of 3.8% from 2017
to 2025. Thyroid gland disorder treatments are indicated for thyroid disorders
that occur in the thyroid gland of a human body. Thyroid disorder is defined as
an abnormal release of thyroid hormones that play a key role in the regulation
of metabolism. The thyroid disease occurs mainly due to a deficiency of iodine
in the body.
Rise in the incidence of
thyroid gland disorder, increase in the number of disease awareness programs
especially in the developing countries, and development of effective
combination drug therapies to treat thyroid gland disorder majorly drive the
growth of the global thyroid gland disorder treatment market. However, side
effects of the drugs leading to low adherence and stringent government
regulations for the approval of combination of therapies hamper the market
growth. Presence of large pool of undiagnosed patients due to asymptomatic
nature of thyroid disorders help to open new avenues for the growth of the
thyroid gland disorder treatment market in the near future.
The global thyroid
gland disorder treatment market is segmented based on disease type,
drug type, route of administration, distribution channel, and region. Based on
disease type, the market is bifurcated into hypothyroidism and hyperthyroidism.
Based on drug type, the market is categorized into levothyroxine, liothyronine,
propylthiouracil, imidazole-based compounds, and others. Based on route of
administration, the market is classified into oral, intravenous, and others.
Based on distribution channel, the market is categorized into wholesaler or
distributor, retailer, mail-order pharmacy, and others. Based on region, it is
analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR
STAKEHOLDERS
- This report entails a
detailed quantitative analysis of the current market trends from 2017 to 2025
to identify the prevailing opportunities.
- Market estimations are based on comprehensive analysis of the key developments in the industry.
- The global market is comprehensively analyzed with respect to disease type, drug type, route of administration, distribution channels, and region.
- In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
- Market estimations are based on comprehensive analysis of the key developments in the industry.
- The global market is comprehensively analyzed with respect to disease type, drug type, route of administration, distribution channels, and region.
- In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Disease Type
- Hypothyroidism
- Hyperthyroidism
- Hyperthyroidism
By Drug Type
- Levothyroxine
- Liothyronine
- Propylthiouracil
- Imidazole-based Compound
- Others
- Liothyronine
- Propylthiouracil
- Imidazole-based Compound
- Others
By Route of
Administration
- Oral
- Intravenous
- Others
- Intravenous
- Others
By Distribution Channel
- Wholesaler/Distributor
- Retailer
- Mail-order Pharmacy
- Others
- Retailer
- Mail-order Pharmacy
- Others
By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Others
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Others
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Others
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Others
KEY PLAYERS PROFILED
- AbbVie Inc.
- Pfizer Inc.
- Merck & Co., Inc.
- Lannett Company, Inc.
- Allergan plc
- Mylan N.V.
GlaxoSmithKline plc
- Novartis AG
- RLC LABS, Inc.
- Abbott Laboratories
- Pfizer Inc.
- Merck & Co., Inc.
- Lannett Company, Inc.
- Allergan plc
- Mylan N.V.
GlaxoSmithKline plc
- Novartis AG
- RLC LABS, Inc.
- Abbott Laboratories
The other players of
the thyroid gland disorder treatment market include (companies not profiled in
the report):
- Takeda Pharmaceutical
Company Limited
- Aspen
- Amgen Inc.
- Endo International plc
- Acella Pharmaceuticals, LLC
- Gemini Laboratories, LLC.
- Aspen
- Amgen Inc.
- Endo International plc
- Acella Pharmaceuticals, LLC
- Gemini Laboratories, LLC.
Get Complete Research Report
with TOC @: https://www.kdmarketinsights.com/product/thyroid-gland-disorder-treatment-market-amr
Table Of Content:
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for
stakeholders
1.3. Key market segments
1.3.1. List of key players
profiled in the report
CHAPTER 2: EXECUTIVE
SUMMARY
2.1.1. CXO perspective
CHAPTER 3: MARKET
OVERVIEW
3.1. Market definition and
scope
3.2. Key findings
3.2.1. Top investment
pockets
3.3. Market share
analysis, 2017
3.4. Porters five forces
analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in
incidence of thyroid gland disorders
3.5.1.2. Development of
effective combination thyroid disorders drug therapies
3.5.1.3. Increase in
number of disease awareness programs in developing regions
3.5.2. Restraints
3.5.2.1. Side effects that
cause lesser patient adherence
3.5.2.2. Stringent
government regulations
3.5.3. Opportunities
3.5.3.1. Availability of
large pool of undiagnosed patients due to asymptomatic nature of thyroid
disorders
CHAPTER 4: THYROID
GLAND DISORDER TREATMENT MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and
forecast
4.2. Hypothyroidism
4.2.1. Key market trends
and growth opportunities
4.2.2. Market size and
forecast
4.2.3. Market analysis, by
country
4.3. Hyperthyroidism
4.3.1. Key market trends
and opportunities
4.3.2. Market size and
forecast
4.3.3. Market analysis, by
country
CHAPTER 5: THYROID GLAND
DISORDER TREATMENT MARKET, BY DRUG TYPE
5.1. Overview
5.1.1. Market size and
forecast
5.2. Levothyroxine
5.2.1. Market size and
forecast
5.2.2. Market analysis, by
country
5.3. Liothyronine
5.3.1. Market size and
forecast
5.3.2. Market analysis, by
country
5.4. Propylthiouracil
5.4.1. Market size and
forecast
5.4.2. Market analysis, by
country
5.5. Imidazole-based
compounds
5.5.1. Market size and
forecast
5.5.2. Market analysis, by
country
5.6. Others
5.6.1. Market size and
forecast
5.6.2. Market analysis, by
country
CHAPTER 6: THYROID
GLAND DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
6.1. Overview
6.1.1. Market size and
forecast
6.2. Oral route
6.2.1. Market size and
forecast
6.2.2. Market analysis, by
country
6.3. Intravenous route
6.3.1. Market size and
forecast
6.3.2. Market analysis, by
country
6.4. Others
6.4.1. Market size and
forecast
6.4.2. Market analysis, by
country
CHAPTER 7: THYROID
GLAND DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL
7.1. Overview
7.1.1. Market size and
forecast
7.2.
Wholesalers/Distributors
7.2.1. Market size and
forecast
7.2.2. Market analysis, by
country
7.3. Retailer
7.3.1. Market size and
forecast
7.3.2. Market analysis, by
country
7.4. Mail-Order Pharmacy
7.4.1. Market size and
forecast
7.4.2. Market analysis, by
country
7.5. Others
7.5.1. Market size and
forecast
7.5.2. Market analysis, by
country
Continue:
About Us:
KD Market Insights offers a comprehensive database of syndicated
research studies, customized reports, and consulting services. These reports
are created to help in making smart, instant and crucial decisions based on
extensive and in-depth quantitative information, supported by extensive
analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement
of the client. We aim at providing value service to our clients. Our reports
are backed by extensive industry coverage and is made sure to give importance
to the specific needs of our clients. The main idea is to enable our clients to
make an informed decision, by keeping them and ourselves up to date with the
latest trends in the market.
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
Telephone: +1 (516) 300-1215
Comments
Post a Comment